Aethlon Medical, Inc.
AEMD
$4.66
$0.4510.69%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 47.02% | 31.48% | -157.89% | 49.37% | 7.50% |
| Total Depreciation and Amortization | 0.13% | -4.07% | -2.21% | -8.42% | 146.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.83% | 4.78% | 2,953.15% | -72.09% | -55.53% |
| Change in Net Operating Assets | -257.04% | -130.08% | 32.29% | -218.83% | 1,430.53% |
| Cash from Operations | 25.10% | 1.87% | 34.80% | 15.43% | 18.10% |
| Capital Expenditure | -- | -- | 144.90% | 75.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 144.90% | 75.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 4,974.10% | -100.00% | -- |
| Repurchase of Common Stock | 13.16% | -5.88% | 59.72% | 24.47% | 61.22% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 98,550.00% | -100.10% | 5,437.79% | -104.01% | 61.22% |
| Foreign Exchange rate Adjustments | 23.53% | -1,092.31% | -4.35% | -342.86% | 563.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 194.37% | -147.81% | 127.12% | 7.72% | 18.68% |